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Abstract: Ghrelin receptor (Ghr-R) signaling in neurons of the ventral tegmental area (VTA) can
modulate dopaminergic function and the reward-related effects of both palatable foods and drugs of
abuse. In this study, we re-introduced the Ghr-R in VTA neurons in Ghr-R knockout mice (Ghr-RVTA
mice) to specifically study the importance of the constitutively active Ghr-R for VTA neuronal
signaling. Our results showed that re-introduction of the Ghr-R in the VTA had no impact on body
weight or food intake under basal conditions. However, during novel environment stress Ghr-RVTA
mice showed increased food intake and energy expenditure compared to Ghr-R knockout mice,
demonstrating the significance of Ghr-R signaling in the response to stress. Ghr-RVTA mice also
showed increased cocaine-induced locomotor activity compared to Ghr-R knockout mice, highlighting
the importance of ghrelin signaling for the reward-related effects of activation of VTA neurons.
Overall, our data suggest that re-introduction of the Ghr-R in the mesolimbic reward system of Ghr-R
knockout mice increases the level of activation induced by both cocaine and novelty stress.
Keywords: ghrelin; ghrelin receptor; ventral tegmental area; energy expenditure; food anticipatory
activity; stress; cocaine sensitivity
1. Introduction
The gut hormone ghrelin exerts many different functions, but one of its most well-described
roles is the regulation of metabolism and food intake, largely mediated by the arcuate nucleus of the
hypothalamus [1]. Reward-related appetite regulation, however, may be mediated through actions
of ghrelin on the mesolimbic dopamine system that connects the ventral tegmental area (VTA) in the
midbrain to the nucleus accumbens (NAc), a part of the ventral striatum [1–4].
The ghrelin receptor (Ghr-R) is highly expressed in neurons in the VTA [2,5] and injection
of ghrelin into the VTA increases dopaminergic output to the NAc, as well as food intake [2,6].
Additionally, intra-VTA administration of a Ghr-R antagonist attenuates the ability of peripheral
ghrelin to increase food intake, highlighting the importance of the mesolimbic system for the orexigenic
effects of ghrelin [2]. Ghrelin also increases reward-seeking behavior and motivation towards obtaining
palatable food [4,7,8] and drugs of abuse [9–11], presumably through action on dopaminergic neurons
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of the VTA. In humans, functional magnetic resonance imaging studies show that ghrelin increases the
activity in regions involved in appetite regulation, including the mesolimbic dopamine system [12].
Independent of the orexigenic effect of ghrelin, Ghr-R signaling also affects the activity of the
sympathetic nervous system to reduce energy expenditure and shift substrate utilization towards
carbohydrates, thus stimulating the accumulation of fat [13–15]. The neurons responsible for these
actions have not been finally determined, but intact β-adrenergic signaling is required [16] and
hypothalamic paraventricular (PVN) neurons have been proposed as the link between the central
nervous system and the sympathetic nervous system [17,18].
The Ghr-R has a high level of constitutive activity and signals with approximately 50% of its
maximal capacity, depending on level of expression, in the absence of ghrelin, shown both in vitro and
in vivo [19–21]. Thus, expression of the Ghr-R in the VTA leads to signaling that may be important
independently of peripheral ghrelin secretion. We have previously demonstrated this effect, using a
mouse model of virus-induced Ghr-R overexpression in the amygdala to evaluate the anxiolytic effect
of Ghr-R signaling [22].
Knockout (KO) of the Ghr-R in mice results in normal or slightly reduced body weight and normal
food intake under basal conditions [23,24]. On a high fat diet, Ghr-R ablation appears to be protective
against diet-induced obesity [25,26]. This phenotype may be due to increased energy expenditure in
combination with decreased food intake. Furthermore, Ghr-R KO mice display normal locomotor
activity, but attenuated food anticipatory activity (FAA) after a feeding entrainment schedule [27–29].
Re-expression of the Ghr-R in dopaminergic neurons of Ghr-R KO mice partly restores ghrelin-induced
food intake [30], underlining the significance of dopaminergic signaling for the orexigenic effect
of ghrelin.
Cocaine very potently increases extracellular dopamine levels in the NAc, an effect that is
augmented by ghrelin. Behaviorally, systemic and intra-NAc administration of ghrelin enhances
cocaine-induced locomotor activity [31,32]. In contrast, treatment with a Ghr-R antagonist reduces
cocaine-induced locomotor activity and NAc dopamine release [10]. Additionally, ghrelin KO mice
are hypo-responsive to the effects of cocaine, reflected in attenuated locomotor activity following
both acute and chronic cocaine injections, compared to wild-type mice [33]. These behavioral effects
correlate with cocaine-induced changes in dopamine turnover in the striatum of wild-type mice that
are not seen in ghrelin KO mice unless pre-treated with ghrelin [33].
Here, we examine the role of the Ghr-R in the VTA in the regulation of parameters demonstrated
to be altered in Ghr-R KO mice, such as basic metabolism, food intake, and FAA, as well as parameters
suggested to be VTA-dependent, e.g., cocaine-induced hyperactivity, and sucrose consumption.
We re-introduce the Ghr-R in the VTA of mice that are completely deficient of the Ghr-R, using
a recombinant adeno-associated virus (rAAV)-mediated approach. This method allows us to study
novel properties of Ghr-R-mediated downstream signaling isolated in this particular region, as the
receptor is not expressed in any other regions. Additionally, we study the expression of genes involved
in regulation of the dopamine system in response to Ghr-R re-introduction. Importantly, the Ghr-R has
a high constitutive activity and the receptor re-introduction on its own may be sufficient to exert an
effect independent of ghrelin availability [19].
2. Results
2.1. Validation of Ghr-R Re-Introduction
To determine whether the rAAV-mediated re-introduction of the Ghr-R in the VTA of Ghr-R
KO mice was successful, we performed autoradiography with 125I-ghrelin. The Ghr-R KO mice with
rAAV-mediated re-introduction of the Ghr-R in the VTA are denoted as Ghr-RVTA mice in this article,
whereas Ghr-R KO mice with rAAV-mediated empty vector construct are denoted as Ghr-R KO mice
or controls. The Ghr-R was able to bind the radiolabeled 125I-ghrelin in the VTA of the Ghr-RVTA mice,
demonstrating a successful re-introduction of the functional Ghr-R in the target area compared to
Int. J. Mol. Sci. 2017, 18, 914 3 of 17
Ghr-R KO control mice (Figure 1A–C). In addition, the receptor was also expressed at low levels in
the nucleus ruber and substantia nigra pars compacta (SNc) located adjacent to the VTA (Figure 1D).
We measured VTA Ghr-R expression at different time points after rAAV surgery and observed the
expression to be increased from four days after virus administration (Figure 1E). rAAVs are efficient at
providing long-term expression [34,35], so we estimated the Ghr-R expression to be stable throughout
the remaining study period.
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namely the VTA, nucleus ruber, substantia nigra pars compacta (SNc) and substantia nigra pars 
reticulata (SNr), n = 7; (E) Ghr-R expression in the VTA of Ghr-RVTA mice at different time points after 
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Figure 1. (A) Representative image of a brain section containing the ventral tegmental area (VTA;
outlined in blue) from a ghrelin receptor (Ghr-R)VTA mouse after autoradiography, showing specific
binding of 125I-ghrelin to the Ghr-R; (B) Representative image of a brain section containing the VTA
from a Ghr-RVTA mouse after autoradiography, showing binding of non-labeled MK677, a Ghr-R
agonist, to visualize non-specific binding of 125I-ghrelin; (C) The corresponding atlas picture with
the VTA outlined in red, a apted from Paxinos & Keith 2001, figure 60 [36]; (D) Ghr-R expression of
Ghr-RVTA mice (+) and Ghr-R kn ckout (KO) control mice (−) in different regions of the midbrain,
namely the VTA, nucleus ruber, substantia nigra pars comp cta (SNc) and substantia nigra pars
reticulata (SNr), n = 7; (E) Ghr-R xpression in the VTA of Ghr-RVTA mice at differ nt time points
after rAAV-mediated re-expression of the receptor in the VTA of Ghr-R KO mice, n = 2. * p ≤ 0.05,
**** p ≤ 0.0001. All data are expr ssed as mean ± SEM.
2.2. Food Intake, RER, and Energy Expenditure of Ghr-RVTA Mice
During the first five weeks after the rAAV surgery, we monitored body weight, body composition,
and food intake weekly, but observed no effect of Ghr-R re-introduction in the VTA on any of these
parameters (Figure 2A–D).
Following the initial five weeks after surgery we placed the animals in an indirect calorimetry
system for metabolic measurements before initiating the F A entrainment schedule. During the first
three days in the novel environment of the calorimetric cages, we analyzed food intake, respiratory
exchange ratio (RER), oxygen consumption (VO2) as a measure of energy expenditure, and locomotor
activity of the animals. RER (VCO2/O2) is a measure of fuel utilization with a RER value of 1 indicating
pure carbohydrate oxidation and an RER value of 0.7 indicating pure fat oxidation. We observed
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significantly-increased food intake, RER values, and VO2 in the Ghr-RVTA mice, compared to Ghr-R
KO control mice, with no difference in locomotor activity (Figure 3A–D). The increase in RER values
could be explained by the increased food intake, as the food consisted of high-carbohydrate chow.
The increased oxygen consumption, which is significantly increased during both dark and light phase,
does not seem to be explained by an increase in activity level, as locomotor activity is similar in both
Ghr-RVTA mice and Ghr-R KO controls.
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Figure 3. (A) Food intake per 4 h and food intake per dark (D) and light (L) cycle of Ghr-RVTA mice (+)
and Ghr-R knockout (KO) control mice (−) in the first three days in the indirect calorimetry cages during
novel environment stress; (B–D) Respiratory exchange ratio (RER) values, oxygen consumption, and
locomotor activity measurements during the same time period. * p ≤ 0.05, ** p ≤ 0.01. n = 7–8. All data
are expressed as mean ± SEM. The stars depicted in the top of the graphs showing development over
time indicate the main effects in a repeated-measures two-way ANOVA, whereas the stars depicted
directly above the time points indicate significance for the given time point when tested post hoc by
applying Fisher’s LSD test.
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After a total of seven days of habituation to the calorimetric cages we again analyzed food intake,
RER, VO2, and locomotor activity for three days as a measure of stable baseline values. During these
baseline measurements we observed no differences in food intake, RER, or locomotor activity between
the two groups, while the Ghr-RVTA mice still displayed a higher oxygen consumption compared to
Ghr-R KO controls (Figure 4A–D).
Our results indicate that the Ghr-RVTA mice had an altered response to a novel, stressful
environment with a small increase in food intake, increased energy expenditure, and utilization
of carbohydrate as an energy source. In a well-known environment after a habituation period, these
values were normalized to levels comparable to the control mice. Only energy expenditure (VO2)
remained elevated under basal conditions.
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Figure 4. (A) Food intake per 4 h and food intake per light/dark cycle of Ghr-RVTA mice (+) and Ghr-R
knockout (KO) control mice (−) after 7–10 days in the indirect calorimetry cages after habituation as a
measure of baseline values; (B–D) Respiratory exchange ratio (RER) values, oxygen consumption, and
locomotor activity measurements during the same time period. * p ≤ 0.05, ** p ≤ 0.01, n = 7–8. All data
are expressed as mean ± SEM. The stars depicted in the top of the graphs showing development over
time indicate the main effects in a repeated-measures two-way ANOVA, whereas the stars depicted
directly above the time points indicate the significance for the given time point when tested post hoc
by applying Fisher’s LSD test.
2.3. Food Anticipatory Activity of Ghr-RVTA Mice
fter a total of 10 days of habituation to the calori etric cages including novelty and baseline
easure ents e initiated 14 days of F entrain ent, during hich the ice only had access to
food for 4 h each day from 10:00–14:00 h (ZT 4–8). Locomotor activity was monitored every day
from 8:00–10:00 h (ZT 2–4) as a measure of the anticipatory activity leading up to the presentation
of food [37,38]. We observed significant FAA after entrainment in both Ghr-R KO control mice and
Ghr-RVTA mice, but there was no difference in activity levels bet een the two groups (Figure 5A–C).
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We also examined whether Ghr-R re-introductio increased the sensitivity of the dopaminergic
ystem in a more direct way by measuring ocaine-induced hyperactivity using the open field est.
The mice w re allowed 30 min of habituation o the open field before they w re injected with ocaine
(10 mg/kg, i.p.) f llowed by 60 min measurement of ocaine-induced hyperactivity. We observed a
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Figure 6. (A) Open field test of Ghr-RVTA mice and Ghr-R knockout (KO) control mice as a measure
of cocaine-induced hyperactivity. Locomotor activity is measured as the distance moved in 10-min
intervals 30 min before (baseline) and 60 min after i.p. injection of cocaine. The star shown in the top
indicates main effects in a repeated-measures two-way ANOVA, whereas the stars directly above the
time points indicate the significance for the given time point when tested post hoc by applying Fisher’s
LSD test. (B) The total distance moved by Ghr-RVTA mice (+) and Ghr-R KO control mice (−) 0–60 min
after i.p. injection of cocaine. * p ≤ 0.05, ** p ≤ 0.01, n = 7–8. All data are expressed as mean ± SEM.
2.5. Basal and Ghrelin-Induced Sucrose Consumption
To investigate the effect of re-introduction of the Ghr-R in the VTA on a food reward-related
parameter, we measured sucrose consumption of Ghr-RVTA mice and Ghr-R KO control mice under
basal conditions and after a peripheral ghrelin injection. We observed no difference in sucrose
Int. J. Mol. Sci. 2017, 18, 914 7 of 17
consumption between the two groups neither under basal conditions nor one hour after ghrelin
administration (Figure 7).
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D2R: dopamine receptor D2; DAT: dopamine transporter; TH: tyrosine hydroxylase. n = 7–8. p-value
TH = 0.067; p-value DAT = 0.159; p-value D2R = 0.159. All data are expressed as mean ± SEM.
3. Discussion
The focus of the present study was to examine the effects of re-introduction of the
constitutively-active Ghr-R in the VTA of Ghr-R-deficient mice on parameters that are affected
in Ghr-R KO mice and parameters regulated via VTA signaling. The purpose of this novel
approach was to evaluate if expression of the Ghr-R in VTA neurons without any Ghr-R-mediated
signaling in the rest of the body could modulate specific functions. Further, this approach allowed
us to evaluate if the constitutive activity of the Ghr-R in the VTA had physiological in vivo
functions. We investigated metabolism and food intake under stressed and basal conditions, FAA,
cocaine-induced hyperlocomotion, and sucrose consumption. We found that, in response to a novel
environment, the Ghr-RVTA mice showed a trend towards increased food intake, and increased RER
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values, while their oxygen consumption was significantly higher, compared to Ghr-R KO control mice.
Under basal conditions, after habituation to the new environment, food intake and RER values of
Ghr-RVTA mice normalized to levels similar to the control mice, whereas we also observed, under
these conditions, increased oxygen consumption of Ghr-RVTA mice compared to controls. We observed
no difference in FAA or basal or ghrelin-induced sucrose consumption between Ghr-RVTA mice and
Ghr-R KO control mice, but Ghr-RVTA mice had increased cocaine-induced hyper-locomotion and
qPCR on VTA tissue samples showed a trend towards increased expression of dopaminergic markers.
We have previously, and successfully, used the model employed in this study, rAAV-mediated
expression of the Ghr-R in a specific brain area, to study the anxiolytic effects of increased Ghr-R
signaling in the amygdala of mice [22]. In our previous study, however, the Ghr-R overexpression
was performed in wild-type mice whereas, in this study, we used Ghr-R KO mice. The advantage
of using Ghr-R KO mice is that it allowed us to examine the effects of Ghr-R signaling, including
constitutively-active ghrelin-independent signaling, in the midbrain, specifically, as the Ghr-R was
only expressed in this region after rAAV surgery. Thus, we were able to dissect functions mediated by
Ghr-R signaling specifically in the VTA, independent of endogenous Ghr-R signaling. We performed
autoradiography with 125I-ghrelin to validate the expression of the Ghr-R and the Ghr-R agonist,
MK677 to visualize specific binding of 125I-ghrelin by displacing it from Ghr-Rs [39]. This technique
allowed us to verify that the receptor was functionally expressed at the protein level and able to bind
ghrelin, thus providing a higher degree of validation than in situ hybridization, which is used in
most studies.
We used a neuron-specific promoter for the Ghr-R expression. As the VTA contains both
dopaminergic and γ-aminobutyric acid (GABA) neurons (approx. 30%) heterogeneously distributed
within the VTA [40], it is very likely that some GABA neurons were targeted by the rAAV and, thus,
expressed the Ghr-R. Abizaid et al. (2005) [2] estimate that approx. 60% of dopaminergic neurons and
30% of GABAergic neurons express the Ghr-R, and our approach may, thus, be more physiologically
relevant than re-introducing the receptor in dopaminergic neurons only, as has previously been
done [30]. However, we do not know the precise expression pattern of the Ghr-R in our study
and how well it mimics the physiological expression pattern of the Ghr-R in the VTA. It is difficult
to speculate on the importance of Ghr-R expression in GABA neurons in relation to our findings.
As the main signaling pathway of the Ghr-R is through Gαq [41,42], increased expression of the
receptor is likely to be associated with increased activation of the targeted neuron through increased
cytosolic Ca2+ concentration. Increased activation of dopaminergic neurons will likely lead to increased
reward signaling, whereas increased GABAergic signaling will lead to augmented inhibition of
the neurons to which the GABA neurons project. These projections include local dopaminergic
neurons of the VTA and cholinergic interneurons in the NAc [40] and increased activation of GABA
neurons may reduce dopaminergic signaling. Activation of VTA dopaminergic neurons using a
DREADD-Gq receptor increases locomotor activity in both mice and rats [43,44]. However, we do
not observe increased locomotion in our study; hence, there appears to be a functional difference
between activating dopaminergic neurons only and activating dopaminergic and GABAergic neurons
in the VTA, perhaps due to increased inhibition from GABAergic neurons on dopaminergic neurons.
Additionally, the short-term Gq-selective neuronal activation induced by DREADD-Gq may mediate a
different functional response, compared to the activation induced by the constitutively-active Ghr-R
that signals through Gαq, Gαi, Gα12/13, and β-arrestin recruitment [45].
As seen in Figure 1C, the virus-induced expression of the Ghr-R was found to leak into some areas
surrounding the VTA, namely the nucleus ruber and SNc. Thus, it cannot be excluded that some of the
effects we observed in this study were due to Ghr-R signaling in these areas. However, the expression
of the receptor in these areas was much lower than in the VTA. Additionally, main functions of the
nucleus ruber and SNc are motor control and locomotor activity, and we do not see any effect of the
Ghr-R re-introduction on these functions. Thus, we estimate that the main contribution to the observed
phenotype of the Ghr-RVTA mice is Ghr-R re-introduction in neurons of the VTA.
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During novel environment stress we observed increased food intake, RER values, and energy
expenditure in Ghr-RVTA mice compared to Ghr-R KO control mice, with no associated increase in
locomotor activity. Introduction to a novel environment enforces stress upon mice and ghrelin is
known to play a significant role in the stress response. Ghrelin secretion is potently stimulated by
adrenergic agonists [46,47] mediated by binding to β1-adrenergic receptors expressed on the gastric
ghrelin-producing cells [47]. Accordingly, ghrelin is released in response to both acute and chronic
stress in rodents [48–50], possibly to counteract stress-induced anxiety and depression, as it has been
demonstrated that ghrelin relieves anxiety and depressive behavior under stressed conditions [22,49].
Some studies show that stress induces hyperphagia and increased weight gain in rodents [30,51],
whereas the opposite is the case in other studies [52,53]. Ghr-R KO mice show increased anxiety and
depression when subjected to stress [49,54], highlighting the potential role of ghrelin as a defender
against the negative effects of stress. In contrast, re-expression of the Ghr-R specifically in dopaminergic
neurons of Ghr-R KO mice restores stress-induced hyperphagia and food-reward behavior, which may
function as a protective coping mechanism against chronic stress [30]. The VTA has previously been
suggested as a site for Ghr-R signaling to exert these putative protective effects in regard to stress [49].
Our results during novel environment stress indicate that re-introduction of the Ghr-R in the VTA
may contribute to the minor stress-induced hyperphagia we observe in Ghr-RVTA mice, but not in
Ghr-R KO mice. As ghrelin levels increase during stress [48–50], it seems probable that Ghr-RVTA
mice have increased activation of VTA neurons during stress via Ghr-R signaling, leading to increased
food intake. Hence, our results indicate that VTA Ghr-R signaling is involved in stress-mediated
hyperphagia, although the difference in food intake between Ghr-R KO mice and Ghr-RVTA mice is
minor, though significant.
The increased RER values we observe in Ghr-RVTA mice compared to controls in response to
novelty stress indicate an increased preference for carbohydrate as energy source over fat, especially
pronounced during the light phase. As the RER value increases along with increased food intake [55],
the increased RER may be a reflection of the increased intake of high-carbohydrate chow observed
in the Ghr-RVTA mice. Normally, mice shift from mainly utilizing carbohydrate as an energy source
during the active dark phase to primarily using fat as an energy source during the light phase when
the mice sleep, reflected in decreased RER values during the light phase.
The increased oxygen consumption without an associated increase in activity we observe in the
Ghr-RVTA mice during both novelty stress and under basal conditions may be due to an increased
activation of the sympathetic nervous system with increased innervation of brown adipose tissue
(BAT). Dopaminergic neurons in the PVN of the hypothalamus have been shown to increase BAT
activation [56] but, to the best of our knowledge, no link between dopaminergic neurons of the VTA
and energy expenditure has been described so far. However, evidence indicates that bidirectional
connections exist between the VTA and the PVN [57,58], a region important for the regulation of energy
expenditure. Neuronal projections to the VTA originate in a diverse collection of brain regions, with
one of the most robust connections coming from the lateral hypothalamus (LH), where stimulation of
projection neurons to the VTA induces feeding and reward-seeking behavior [59–62]. The VTA itself
projects mainly to the NAc, prefrontal cortex, amygdala, and hippocampus [63]. The NAc has been
suggested to project to the LH among many other regions [64], creating a complex and incompletely
understood neurocircuitry. The effect on energy expenditure we observed when re-introducing the
Ghr-R in the VTA of Ghr-R KO mice is unexpected and suggests a novel function for the VTA in the
regulation of energy expenditure.
When food is only available during a restricted and predictable time of day, mice exhibit FAA,
which involves an increase in locomotor activity preceding the presentation of food. Ghrelin levels
are elevated prior to the presentation of food after entrainment to a restricted feeding schedule and
ghrelin administration increases FAA [28]. It has previously been shown that Ghr-R KO mice display
reduced FAA compared to wild-type mice [27–29] and acute and chronic treatment with a Ghr-R
antagonist reduces FAA [29]. In our study, however, we observed similarly high levels of FAA in
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both the control Ghr-R KO mice and in the mice expressing the Ghr-R selectively in VTA neurons.
These results indicate that Ghr-R signaling in the VTA is not sufficient to regulate the FAA response
or that Ghr-R signaling is not important for FAA, as we observed substantial FAA in Ghr-R KO mice,
contrary to other studies [27,28].
The Ghr-RVTA mice showed increased cocaine-induced locomotor activity as compared to controls.
It has previously been shown that seven days of systemic ghrelin does not change basal locomotor
activity in rats, but it enhances the response to cocaine [65]. These results are in line with our findings
that the Ghr-RVTA mice show normal basal locomotor activity, but increased hyperlocomotion in
response to cocaine administration. Our results suggest that chronic VTA Ghr-R expression is not
enough to affect basal locomotor activity of Ghr-R KO mice. However, when the dopamine system
was pharmacologically challenged with cocaine, we observed an increased sensitivity after VTA
Ghr-R re-introduction. Thus, our results underline the importance of Ghr-R signaling in the VTA
for the function of the dopamine system in relation to psychostimulants. In line with this, the acute
hyperlocomotion- and conditioned place preference-inducing effects of ethanol, cocaine, amphetamine,
and nicotine are attenuated or ablated by antagonism of the Ghr-R [9,10,66]. Heterodimerization
between the Ghr-R and the dopamine receptor D1 (D1R) has been shown to amplify dopamine
signaling in neurons that co-express the Ghr-R and the D1R [67] and this mechanism may contribute
to the effect we observe. Supportive of increased dopaminergic signaling in Ghr-RVTA mice, there was
a trend towards increased expression of the dopaminergic markers, TH, DAT, and D2R in the VTA
of these mice compared to controls, but the effects did not achieve statistical significance. Increased
expression of enzymes involved in dopaminergic synthesis, reuptake, and activity is in line with the
stimulatory effect ghrelin has on these neurons [68,69]. We did not observe any difference between
Ghr-RVTA mice and Ghr-R KO control mice on sucrose consumption under basal conditions, or after a
peripheral administration of ghrelin. Thus, it appears that Ghr-R expression in the VTA is not sufficient
to affect consumption of a rewarding substance. VTA ghrelin signaling has previously been implicated
as a mediator of reward-related behavior in regards to palatable foods [4,7,8]. However, in previous
studies, ghrelin has been administered directly into the VTA of wild-type mice with intact Ghr-R
signaling throughout the brain. Our results suggest that the ability of peripheral ghrelin to induce
increased intake of palatable substances requires intact Ghr-R signaling outside of the VTA.
In conclusion, we showed in this study that Ghr-R re-introduction in the VTA of Ghr-R KO mice
increased food intake, RER, and oxygen consumption in response to novel environment stress. Only the
effect on oxygen consumption was also present under basal unstressed conditions. Our findings
indicate a new potential role for Ghr-R activation in the VTA to regulate energy expenditure directly
or indirectly. Ghr-R re-introduction in the VTA of Ghr-R KO mice had no effect on food anticipatory
activity, or sucrose consumption, but significantly increased cocaine-induced hyperlocomotion.
These findings underline the importance of ghrelin signaling for the reward-related effects of activation
of VTA neurons.
4. Materials and Methods
4.1. Animals and Drugs
Male Ghr-R KO mice (C57BL/6J background, fully backcrossed, aged 8–11 weeks at the time
of surgery, n = 7–8) [25] were used. All mice were socially housed in Macrolon cages until surgery,
after which they were single housed for the duration of the study. Cages were enriched with housing
and nesting material and kept at constant temperature (22 ± 2 ◦C) in a 12-h light/dark cycle with
lights on at 6:00 h (ZT 0). Animals had free access to a chow diet (Altromin #1310, Brogaarden,
Lynge, Denmark) and water unless otherwise specified. All experiments were approved by the
Danish Animal Experimentation Inspectorate and conducted according to institutional guidelines
(license no. 2012-15-2934-00054, approval 14 May 2009). Human ghrelin (Polypeptide Laboratories,
Hillerød, Denmark) was dissolved in 0.9% saline and injected subcutaneously (s.c., 2 mg/kg). Cocaine
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(HS Pharmacy, Copenhagen, Denmark) was dissolved in 0.9% saline and injected intraperitoneally
(i.p., 10 mg/kg). The drug solutions were prepared immediately before use.
4.2. Recombinant Adeno-Associated Virus Injections
The rAAV vectors (GeneDetect, Auckland, New Zealand) were derived from a mixture of
serotypes 1 and 2. The vectors contained an inserted transgene, encoding the full-length cDNA
for the human Ghr-R containing a FLAG polypeptide tag added to the N-terminus of the receptor
(stock solution: rAAV-Ghr-R; 1× 1012 genomic particles/mL). An empty vector without transgene was
used as the control (rAAV-Ctrl; 1 × 1012 genomic particles/mL). The transgene was sub-cloned into an
rAAV expression cassette, which consisted of the rat neuron-specific enolase promoter, the woodchuck
post-transcriptional regulatory element and a bovine growth hormone polyA signal flanked by rAAV
inverted terminal repeats. The injections were performed as previously described [70,71]. Briefly, the
mice were pre-treated with a mixture of the analgesics Rimadyl (5 mg/kg, Pfizer, New York City,
NY, USA) and Temgesic (0.06 mg/kg, Reckit Benckiser, Berkshire, UK) and the antibiotic Baytril
(10 mg/kg, Bayer Healthcare, Leverkusen, Germany) before they were anaesthetized using isoflurane
gas anesthesia (Baxter, San Juan, Puerto Rico). Following anesthesia, they were placed into a stereotaxic
frame (Kopf Instruments, Tujunga, CA, USA), and a total volume of 1 µL viral vector suspension was
injected through a glass pipette at 0.2 µL/min bilaterally into the VTA (anterior-posterior: −3.3 mm
and medial-lateral: ±0.5 mm relative to Bregma; dorsal-ventral: 4.5 mm relative to skull surface, 1 µL
at each injection site) [36]. After injection, the injection pipette was left in place for 3 min to minimize
the backflow of viral particles through the injection track. Post-operatively, the mice received daily
treatment with analgesic (Rimadyl, 5 mg/kg) and antibiotic (Baytril, 10 mg/kg) for two days.
4.3. Verification of rAAV-Mediated Re-Introduction of the Ghrelin Receptor
On the day of termination, the mice were decapitated and their brains removed and frozen on
powdered dry ice. The brains were cut into 14 µm coronal sections through the VTA using a cryostat
(Leica Microsystems CM3050 S, Wetzlar, Germany), mounted on Superfrost plus glass slides and kept
at −80 ◦C until further use.
Autoradiography
The slides were thawed at room temperature and pre-incubated for 20 min in binding buffer
(pH 7.4), containing 25 mM N-(2-hydroxyethyl)piperazine-N0-(2-ethanesulphonic acid) (HEPES),
2.5 mM CaCl2, 1 mM MgCl2, 0.5 g/L bacitracin, and 0.5 g/L bovine serum albumin. The slides were
then incubated at room temperature for 60 min in binding buffer containing 0.15 nM [125I][His]-ghrelin
(Perkin Elmer, NEX388, Waltham, MA, USA) to which 1 µM non-labeled MK677 (Tocris, Bristol, UK)
was added to visualize specific binding. After a brief rinse, the slides were washed for 5 min in binding
buffer at 4 ◦C and subsequently air-dried, before being exposed to 125I-sensitive Kodak Biomax MS
films (Amersham Biosciences, Little Chalfont, UK) for four days at room temperature. The films were
developed in a Kodak GBX developer.
4.4. Body Weight, Body Composition, and Food Intake
In order to observe a potential effect of the intra-VTA Ghr-R re-introduction on body weight and
body composition, the mice were monitored weekly from just before rAAV surgery and throughout
the first five weeks after surgery. Every week, the mice were weighed and their body composition
analyzed by quantitative magnetic resonance imaging (MRI) using echo-MRI (Echo Medical Systems,
Houston, TX, USA). At the same time the average weekly food intake was registered manually by
weighing the content of the food hoppers.
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4.5. Indirect Calorimetry
Following the five weeks of body composition measurements, oxygen consumption, food intake,
RER, and locomotor activity of the mice were assessed using a 16-chamber indirect calorimetry
system (PhenoMaster; TSE Systems, Bad Homburg, Germany) as previously described [55]. Briefly,
measurements of food intake (g), RER (VCO2/VO2), oxygen consumption (VO2: mL/h/kg), and
ambulatory activity (consecutive beam breaks) were sampled at the first three days of housing in the
new calorimetric cages to evaluate novel environment stress and again after four additional days of
acclimatization to evaluate baseline metabolism.
4.6. Food Anticipatory Activity
After 10 days of acclimatization and baseline measurement in the calorimetric cages the mice
were put on scheduled feeding, with access to food only from 10:00 to 14:00 h (ZT 4–8) each day for
14 days with free access to water. Food intake and locomotor activity were measured continuously
throughout the experiment. FAA was registered as total ambulatory activity (consecutive beam breaks)
in the 2 h preceding food presentation (8:00–10:00 h; ZT 2–4) [37,38].
4.7. Open Field Locomotor Test
Four months after the FAA experiments, the mice were subjected to an open field locomotor test.
The mice were placed in the center of the open field arena (40 cm × 40 cm with 65 cm walls) [71].
Baseline locomotor activity was measured for 30 min after which the mice were injected with cocaine
(10 mg/kg, i.p.) and locomotor activity measured for 60 min. Each session was recorded and later
scored for locomotor activity using Ethovision software (Noldus Information Technology, Wageningen,
The Netherlands) by center-point detection.
4.8. Basal and Ghrelin-Induced Sucrose Consumption
Mice were moved to the experimental room 1 h before the start of the experiment and placed in an
empty cage with only bedding material. Mice had access to water and a 10% sucrose solution. After 1 h
of access, intake of water and sucrose solution was measured. On a separate day mice received an
injection of ghrelin (2 mg/kg, s.c.) before being placed in the cage and intake was again measured
after 1 h of access.
4.9. Expression of Dopaminergic Markers in the VTA
4.9.1. Laser Capture Microdissection (LCM)
The VTA was collected bilaterally from three 14-µm coronal sections per animal on Superfrost
plus glass slides. Brain sections were stained for 1 min with 0.1% cresyl violet acetate (Sigma-Aldrich,
Brøndby, Denmark) dissolved in 70% EtOH. Sections were subsequently dehydrated briefly in 96% and
99.9% EtOH and finally dried at room temperature for at least 2 min. Using a PALM Microdissection
instrument (Zeiss Microsystems, Jena, Germany), the VTA was identified and captured on Capsure
Macro LCM Caps (Life Technologies, Applied Biosystems, Carlsbad, CA, USA).
4.9.2. RNA Extraction and cDNA Synthesis from LCM Dissected Samples
Cell lysis and RNA extraction were performed using the RNeasy Micro Kit with DNase digestion
according to the manufacturer’s instructions (Qiagen, Copenhagen, Denmark). The RNA was eluted
in 14 µL RNase-free H2O and cDNA for qPCR analysis was produced using SuperScript III (Invitrogen,
Nærum, Denmark).
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4.9.3. Quantitative Reverse Transcription (qRT)-PCR Analysis
We used a fixed cDNA volume of 0.83 µL cDNA per sample, diluted 1:6 in RNase-free H2O.
RT-qPCR analysis was performed on a LightCycler480 (Roche Applied Science, Penzberg, Germany)
using PrecisionPLUS Mastermix premixed with SYBRgreen (Primerdesign, Chandler's Ford, UK).
The expression levels of the genes of interest were normalized to the average expression of the
housekeeping genes TATA-box binding protein (TBP) and tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein, zeta (YWHAZ), using the ∆∆Ct method [72]. All runs consisted
of a pre-incubation step at 95 ◦C for 2 min followed by 45 cycles of 95 ◦C, 15 s; 60 ◦C, 45 s. The
following forward (F) and reverse (R) primers were used: tyrosine hydroxylase (TH) F: CCT GGG
AGA ACT GGG CAA ATG and R: CCG TCA TGC CTC CTC ACC TAT G; dopamine transporter (DAT)
F: TGC TCT ACT TCA GCC TGT CG and R: TAT GCT CTG ATG CCA TCC AT; dopamine receptor D2
(D2R) F: GAC TCA ACA ACA CAG ACC AG and R: CGT AGA ACG AGA CGA TGG A. All analyses
were performed in duplicate.
4.10. Statistics
All data was analyzed using GraphPad Prism 6.0 (Graphpad Software, San Diego, CA, USA).
An unpaired two-tailed Student’s t-test was used when the means of two groups were compared. When
more than two groups were compared, two-way analysis of variance (ANOVA) was used, followed
by Fisher’s LSD post-hoc test for comparison of individual groups when appropriate. The level of
significance was set at p ≤ 0.05 and all data are presented as mean ± standard error of the mean (SEM).
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